Related Experiment Video
Updated: Aug 27, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Hemostatic function of cold-stored platelets in a thrombocytopenic rabbit bleeding model
Masayuki Nogawa1, Naohide Watanabe2, Toshiyasu Koike1
1Department of Research and Development, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Cold-stored platelet concentrates (CS-PCs) show comparable hemostatic effectiveness to room temperature-stored (RTS) platelets in thrombocytopenic rabbits. Increasing CS-PC dosage may enhance hemostatic efficacy in patients with severe thrombocytopenia.
Area of Science:
- Hematology
- Transfusion Medicine
- Thrombosis and Hemostasis
Background:
- Cold-stored platelet concentrates (CS-PCs) are increasingly used for massive bleeding.
- Their in vivo hemostatic function in severe thrombocytopenia remains under-evaluated.
- This study investigates the efficacy of CS-PCs in a preclinical model of thrombocytopenia.
Purpose of the Study:
- To evaluate the in vivo hemostatic function of plasma-depleted human CS-PCs compared to room temperature-stored (RTS) PCs.
- To assess the efficacy of these transfusions in rabbits with induced severe thrombocytopenia.
- To determine if storage temperature affects platelet hemostatic performance.
Main Methods:
- Human apheresis platelets were processed and stored at cold (4°C) or room temperature (20-24°C) in platelet additive solution (PAS).
- Rabbits with busulfan-induced thrombocytopenia and a blocked reticuloendothelial system received transfusions of RTS- or CS-PAS-PCs.
- Hemostatic efficacy was measured by ear bleeding time, and platelet counts were monitored post-transfusion.
Main Results:
- Both RTS- and CS-PAS-PCs achieved 100% hemostasis on day 3.
- On days 6 and 9, hemostatic rates were comparable between RTS- and CS-PAS-PCs, although not statistically significant (p > 0.05).
- Platelet counts were significantly lower after CS-PAS-PC transfusion compared to RTS-PAS-PC, particularly on day 9 (p=0.0007).
Conclusions:
- CS-PAS-PCs may provide similar hemostasis to RTS-PAS-PCs in thrombocytopenic patients with mild bleeding.
- Higher doses of CS-PAS-PCs might be necessary to achieve optimal hemostatic efficacy.
- Further studies are warranted to optimize CS-PC transfusion strategies.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

